Latest filing published 24 Nov 2025 for RESMED INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Harjit Gill: trading record in brief
Harjit Gill, listed as board member, appears in our data through filings on ResMed Inc shares, published by SEC (Form 4). We count 13 filings; the first trade dates from 21 November 2019 and the latest from 20 November 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 24 November 2025: a share grant, in ResMed Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Harjit Gill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,073 shares0ResMed Common StockSEC:0000943819-25-000175:0
- 38.209 shares@ US$250.1014.0% of flowResMed Common StockSEC:0000943819-25-000119:0
- 1,083 shares0ResMed Common StockSEC:0001127602-24-027900:0
- 132.601 shares@ US$252.3861.3% of flowResMed Common StockSEC:0001127602-24-027099:0
- 1,768 shares0ResMed Common StockSEC:0001127602-23-028086:0
- 79.202 shares@ US$143.6020.9% of flowResMed Common StockSEC:0001127602-23-027452:0
- 1,122 shares0ResMed Common StockSEC:0001127602-22-026072:0
- 41 shares@ US$225.1817.8% of flowResMed Common StockSEC:0001127602-22-025667:0
- 956 shares0ResMed Common StockSEC:0000943819-21-000035:0
9 of 9 declarations
